The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines
Abstract
Cell penetrating peptides (CPPs) are useful tools to deliver low‐molecular‐weight cargoes into cells; however, their mode of uptake is still controversial. The most efficient CPPs belong to the group of arginine‐rich peptides, but a systematic assessment of their potential toxicity is lacking. In this study we combined data on the membrane translocation abilities of oligo‐arginines in living cells as a function of their chain length, concentration, stability and toxicity. Using confocal microscopy analysis of living cells we evaluated the transduction frequency of the L‐isoforms of oligo‐arginines and lysines and then monitored their associated toxicity by concomitant addition of propidium iodide. Whereas lysines showed virtually no transduction, the transduction ability of arginines increased with the number of consecutive residues and the peptide concentration, with L‐R9 and L‐R10 performing overall best. We further compared the L‐ and D‐R9 isomers and found that the D‐isoform always showed a higher transduction as compared to the L‐counterpart in all cell types. Notably, the transduction difference between D‐ and L‐forms was highly variable between cell types, emphasizing the need for protease‐resistant peptides as vectors for drug delivery. Real‐time kinetic analysis of the D‐ and L‐isomers applied simultaneously to the cells revealed a much faster transduction for the D‐variant. The latter underlies the fact that the isomers do not mix, and penetration of one peptide does not perturb the membrane in a way that gives access to the other peptide. Finally, we performed short‐ and long‐term cell viability and cell cycle progression analyses with the protease‐resistant D‐R9. Altogether, our results identified concentration windows with low toxicity and high transduction efficiency, resulting in fully bioavailable intracellular peptides. Copyright © 2007 European Peptide Society and John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Cited by
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T.-Y., & Pellois, J.-P. (2012) · Pharmaceuticals · doi:10.3390/ph5111177 · Cited by 384
Kristensen, M., Birch, D., & Mørck Nielsen, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020185 · Cited by 304
Farkhani, S. M., Valizadeh, A., Karami, H., Mohammadi, S., Sohrabi, N., & Badrzadeh, F. (2014) · Peptides · doi:10.1016/j.peptides.2014.04.015 · Cited by 273
Reissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
Metadata
- Authors
- Tünnemann, G., Ter‐Avetisyan, G., Martin, R. M., Stöckl, M., Herrmann, A., & Cardoso, M. C.
- Venue
- Journal of Peptide Science
- Publisher
- Wiley
- Published
- 2007-12-11
- Volume
- 14
- Issue
- 4
- Pages
- 469-476
- ISSN
- 1075-2617 (ISSN-L)
- 1099-1387
- OpenAlex
- W2062253976
- Cited by
- 286
- References
- 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.